The mutagenic properties of the nucleosides of pyrimidine analogues in Drosophila melanogaster.
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D003561:Cytarabine / Q000494:pharmacology*; D003857:Deoxyuridine / Q000494:pharmacology*; D004330:Drosophila / Q000187:drug effects*; D005467:Floxuridine / Q000532:radiotherapy*; D009153:Mutagens / Q000494:pharmacology*; D009154:Mutation; D009705:Nucleosides / Q000494:pharmacology*
D000963:Antimetabolites; D009153:Mutagens; D009705:Nucleosides; D005467:Floxuridine; D003561:Cytarabine; D001973:Bromodeoxyuridine; D003857:Deoxyuridine